Sulfated oligosaccharides: New targets for drug development?

Current Medicinal Chemistry

Volumn 16, Issue 18, 2009, Pages 2338-2344

  Kovensky, José ^a  

^a UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALPHA CYANO 4 HYDROXYCINNAMIC ACID; ALPHA GLUCOSIDASE INHIBITOR; CHONDROITIN SULFATE; DNA BINDING PROTEIN; ERYTHROPOIETIN; GLYCOPROTEIN; GLYCOSAMINOGLYCAN; MEMBRANE PROTEIN; MIGLITOL; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MECA 79; MUCIN; MYELIN; OLIGOSACCHARIDE; OLIGOSACCHARIDE SULFATE; PROTEIN C; SALACINOL; SULFOLIPID I; UNCLASSIFIED DRUG; SULFATE;

CARBOHYDRATE ANALYSIS; CELL ADHESION; CELLULAR IMMUNITY; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HUMORAL IMMUNITY; IMMUNOHISTOCHEMISTRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR IMPRINTING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEOMICS; REVIEW; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; UNSPECIFIED SIDE EFFECT; X RAY CRYSTALLOGRAPHY; ANIMAL; CHEMISTRY; DRUG DESIGN; IMMUNOLOGY; MASS SPECTROMETRY; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; DRUG DESIGN; HUMANS; MOLECULAR IMPRINTING; OLIGOSACCHARIDES; PROTEIN BINDING; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STRUCTURE-ACTIVITY RELATIONSHIP; SULFURIC ACID ESTERS;

EID: 67949123322     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709788453096     Document Type: Review

References (66)

1. Bernstein, H.B.; Compans, R.W. Sulfation of the human immunodeficiency virus envelope glycoprotein. J. Virol., 1992, 66, 6953-6959.
2. (a) Van Rooijen, J.J.M.; Kamerling, J.P.; Vliegenthart, J.F. Sulfated di-, tri- and tetraantennary N-glycans in human Tamm-Horsfall glycoprotein. Eur. J. Biochem., 1998, 256, 471-487.
3. (b) Green, E.D.; van Halbeek, H.; Boime, I.; Baenziger, J.U. Structural elucidation of the disulfated oligosaccharide from bovine lutropin. J. Biol. Chem., 1985, 260, 15623-15630.
4. (c) Noguchi, N.; Nakano, M. Structure of the acidic N-linked carbohydrate chains of the 55-kDa glycoprotein family (PZP3) from porcine zona pellucida. Eur. J. Biochem., 1992, 209, 883-894.
5. (d) Pierce, M.; Arango, J. Rous sarcoma virus-transformed baby hamster kidney cells express higher levels of asparagine-linked tri- and tetraantennary glycopeptides containing [GlcNAc-beta (1,6)Man-alpha (1,6)Man] and poly-N-acetyllactosamine sequences than baby hamster kidney cells. J. Biol. Chem., 1986, 261, 10772-10777.
6. Kawasaki, N.; Ohta, M.; Hyuga, S.; Hyuga, M.; Hayakawa, T. Application of liquid chromatography/mass spectrometry and liquid chromatography with tandem mass spectrometry to the analysis of the site-specific carbohydrate heterogeneity in Erythropoietin Anal. Biochem., 2000, 285, 82-91.
7. (b) Honke, K.; Taniguchi, N. Sulfotransferases and sulfated oligosaccharides. Med. Res. Rev., 2002, 22, 637-654.
8. Petry, K.; Nudelman, E.; Eisen, H.; Hakomori, S. Sulfated lipids represent common antigens on the surface of Trypanosoma cruzi and mammalian tissues. Mol. Biochem. Parasitol., 1988, 30, 113-121.
9. (b) Uhrig, M.L., Couto, A.S.; Zingales, B.; Colli, W.; Lederkremer, R.M. Metabolic labelling and partial characterisation of a sulfoglycolipid in Trypanosoma cruzi trypomastigotes. Carbohydr. Res., 1992, 231, 329-334.
10. Barboza, M.; Duschak, V.G.; Fukuyama, Y.; Nonami, H.; Erra-Balsells, R.; Cazzulo, J.J.; Couto, A.S. Structural analysis of the N-glycans of the major cysteine proteinase of Trypanosoma cruzi. Identification of sulfated high-mannose type oligosaccharides. FEBS J., 2005, 272, 3803-3815.
11. Freeze, H.H.; Wolgast, D. Structural analysis of N-linked oligosaccharides from glycoproteins secreted by Dictyostelium discoideum. Identification of mannose 6-sulfate. J. Biol. Chem., 1986, 261, 127-134.
12. Honke, K.; Zhang, Y.; Cheng, X.; Kotani, N.; Taniguchi, N. Biological roles of sulfoglycolipids and pathophysiology of their deficiency. Glycoconj. J., 2004, 21, 59-62.
13. Goren, M.B.; Brokl, O.; Roller, P.; Fales, H.M.; Das, B.C. Sulfatides of Mycobacterium tuberculosis: The structure of the principal sulfatide (SL-I). Biochemistry, 1976, 15, 2728-2735.
14. Leigh, C.D.; Bertozzi, C.R. Synthetic studies toward Mycobacterium tuberculosis Sulfolipid-I. J. Org. Chem., 2008, 73, 1008-1017.
15. For a recent review see: Lindhardt, R.J.; Toida, T. Role of glycosaminoglycans in cellular communication. Acc. Chem. Res., 2004, 37, 431-438.
16. Yu, G.; Zhao, X.; Yang, B.; Ren, S.; Guan, H.; Zhang, Y.; Lawson, A.M.; Chai, W. Sequence determination of sulfated carrageenan-derived oligosaccharides by high-sensitivity negative-ion electrospray tandem mass spectrometry. Anal. Chem., 2006, 78, 8499- 505.
17. Kawasaki, N.; Haishima, Y.; Ohta, M.; Itoh, S.; Hyuga, M.; Hyuga, S.; Hayakawa, T. Structural analysis of sulfated N-linked oligosaccharides in erythropoietin. Glycobiology, 2001, 11, 1043-1049.
18. Gunay, N.S.; Tadano-Aritomi, K.; Toida, T.; Ishizuka, I.; Linhardt, R.J. Evaluation of counterions for electrospray ionization mass spectral analysis of a highly sulfated carbohydrate, sucrose octasulfate. Anal. Chem., 2003, 75, 3226-3231.
19. (a) Pope, R.M.; Raska, C.S.; Thorp, S.C.; Liu, J. Analysis of heparan sulfate oligosaccharides by nano-electrospray ionization mass spectrometry. Glycobiology, 2001, 11, 505-513.
20. (b) Kuberan, B.; Lech, M.; Zhang, L.; Wu, Z.L.; Beeler, D.L.; Rosenberg, R.D. Analysis of heparan sulfate oligosaccharides with ion pair-reverse phase capillary high performance liquid chromatography-microelectrospray ionisation time-of-flight mass spectrometry. J. Am. Chem. Soc., 2002, 124, 8707-8718.
21. Wheeler, S.F.; Harvey, D.J. Extension of the in-gel release method for structural analysis of neutral and sialylated N-linked glycans to the analysis of sulfated glycans: Application to the glycans from bovine thyroid-stimulating hormone. Anal. Biochem., 2001, 296, 92-100.
22. Tissot, B.; Gasiunas, N.; Powell, A.K.; Ahmed, Y.; Zhi Z.; Haslam S.M.; Morris, H.R.; Turnbull, J.E.; Gallagher, J.T.; Dell, A. Towards GAG glycomics: Analysis of highly sulfated heparins by MALDI-TOF mass spectrometry. Glycobiology, 2007, 17, 972-982.
23. Fukuyama, Y.; Nakaya, S.; Yamazaki, Y.; Tanaka, K. Ionic liquid matrixes optimized for MALDI-MS of sulfated/sialylated/neutral oligosaccharides and glycopeptides. Anal. Chem., 2008, 80, 2171- 179.
24. Laremore, T.N.; Zhang, F.; Linhardt, R.J. Ionic liquid matrix for direct UV-MALDI-TOF-MS analysis of dermatan sulfate and chondroitin sulfate oligosaccharides. Anal. Chem., 2007, 79, 1604- 610.
25. Wolff, J.J.; Amster, I.J.; Chi, L.; Linhardt, R.J. Electron detachment dissociation of glycosaminoglycan tetrasaccharides. J. Am. Soc. Mass Spectrom., 2007, 18, 234-244.
26. (a) van Kuppevelt, T.H.; Dennissen, M.A.B.A.; van Venrooij, W.J.; Hoet, R.M.A.; Veerkamp, J.H. Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. J. Biol. Chem., 1998, 273, 12960-12966.
27. (b) Jenniskens, G.J.; Hafmans, T.; Veerkamp, J.H.; van Kuppevelt, T.H. Spatiotemporal distribution of heparan sulfate epitopes during myogenesis and synaptogenesis: A study in developing mouse intercostal muscle. Dev. Dyn., 2002, 225, 70-79.
28. Ten Dam, G.B.; Kurup, S.; van de Westerlo, E.M.A.; Versteeg, E.M.M.; Lindahl, U.; Spillmann, D.; van Kuppevelt, T.H. 3-O-Sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3. J. Biol. Chem., 2006, 281, 4654-4662.
29. Wijnhoven, T.J.; van de Westerlo, E.M.; Smits, N.C.; Lensen, J.F.; Rops, A.L.; van der Vlag, J.; Berden, J.H.; van den Heuvel, L.P.; van Kuppevelt, T.H. Characterization of anticoagulant heparinoids by immunoprofiling. Glycoconj. J., 2008, 25, 177-185
30. Tsubokawa, D.; Goso, Y.; Sawaguchi, A.; Kurihara, M.; Ichikawa, T.; Sato, N.; Suganuma, T.; Hotta, K.; Ishihara, K. A monoclonal antibody, PGM34, against 6-sulfated blood-group H type 2 antigen, on the carbohydrate moiety of mucin. FEBS J., 2007, 274, 1833-1848.
31. Bodger, K.; Campbell, F.; Rhodes, J.M. Detection of sulfated glycoproteins in intestinal metaplasia: A comparison of traditional mucin staining with immunohistochemistry for the sulfo-Lewis(a) carbohydrate epitope. J. Clin. Pathol., 2003, 56, 703-708.
32. Uchimura, K.; Rosen, S.D. Sulfated L-selectin ligands as a therapeutic target in chronic inflammation. Trends Immunol., 2006, 27, 559-565.
33. Acosta, D.M.; Arnaiz, M.R.; Esteva1, M.I.; Barboza, M.; Stivale, D.; Orlando, U.D.; Torres, S.; Laucella, S.A.; Couto, A.S.; Duschak, V.G. Sulfates are main targets of immune responses to cruzipain and are involved in heart damage in BALB/c immunized mice. Int. Immunol., 2008, 20, 461-470.
34. Siñeriz, F.; Ikeda, Y.; Petit, E.; Bultel, L.; Haupt, K.; Kovensky, J.; Papy-Garcia, D. Toward an alternative for specific recognition of sulfated sugars. Preparation of highly specific molecular imprinted polymers. Tetrahedron, 2007, 63, 1857-1862.
35. Gesslbauer, B.; Kungl, A.J. Glycomic approaches toward drug development: therapeutically exploring the glycosaminoglycanome. Curr. Opin. Mol. Ther., 2006, 8, 521-528.
36. Ikeda, Y.; Siñeriz, F.; Bultel, L.; Grand, E.; Kovensky, J.; Papy-Garcia, D. Synthesis of a trisulfated heparan sulfate disaccharide analog and its use as a template for preliminary molecular imprinting studies. Carbohydr. Res., 2008, 343, 587-595.
37. Cardin, A.D.; Weintraub, H.J.R. Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis, 1989, 9, 21-32.
38. WuDunn, D.; Spear, P.G. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol., 1989, 63, 52-58.
39. Feyzi, E.; Trybala, E.; Bergström, T.; Lindahl, U.; Spillmann, D. Structural requirement of heparan sulfate for interaction with herpes simplex virus type 1 virions and isolated glycoprotein C. J. Biol. Chem., 1997, 272, 24850-24857.
40. (a) Shukla, D.; Liu, J.; Blaiklock, P.; Shworak, N.W.; Bai, X.; Esko, J.D.; Cohen, G.H.; Eisenberg, R.J.; Rosenberg, R.D.; Spear, P.G. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell, 1999, 99, 13-22.
41. (b) Xia, G.; Chen, J.; Tiwari, V.; Ju, W.; Li, J.-P.; Malmstrom, A.; Shukla, D.; Liu, J. Heparan sulfate 3-O-sulfotransferase isoform 5 generates both an antithrombin-binding site and an entry receptor for herpes simplex virus, type 1. J. Biol. Chem., 2002, 277, 37912-37919.
42. Spear, P.G.; Longnecker, R. Herpesvirus entry: An update J. Virol., 2003, 77, 10179-10185.
43. (b) Liu, J.; Shriver, Z.; Pope, R.M.; Thorp, S.C., Duncan, M.B.; Copeland, R.J.; Raska, C.S.; Yoshida, K.; Eisenberg, R.J.; Cohen, G.; Linhardt, R.J.; Sasisekharan, R. Characterization of a heparan sulfate octasaccharide that binds to herpes simplex virus type 1 glycoprotein D. J. Biol. Chem., 2002, 277, 33456-33467.
44. Adamiak, B.; Ekblad, M.; Bergstrom, T.; Ferro, V.; Trybala, E. Herpes simplex virus type 2 glycoprotein G is targeted by the sulfated oligo- and polysaccharide inhibitors of virus attachment to cells. J. Virol., 2007, 81, 13424-13434.
45. Fry, E.E.; Lea, S.M.; Jackson, T.; Newman, J.W.I.; Ellard, F.M.; Blakemore, W.E.; Abu-Ghazaleh, R.; Samuel, A.; King, A.M.Q.; Stuart, D.I. The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. EMBO J., 1999, 18, 543-554.
46. Roderiquez, G.; Oravecz, T.; Yanagishita M.; Bou-Habib, D.C.; Mostowski, H.; Norcross, M.A. Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41. J. Virol., 1995, 69, 2233-2239.
47. Moulard, M.; Lortat-Jacob, H.; Mondor, I.; Roca, G.; Wyatt, R.; Sodroski, J.; Zhao, L.; Olson, W.; Kwong, P.D.; Sattentau, Q.J. Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120. J. Virol., 2000, 74, 1948-1960.
48. Gama, C.I.; Hsieh-Wilson, L.C. Chemical approaches to deciphering the glycosaminoglycan code. Curr. Opin. Chem. Biol., 2005, 9, 609-619.
49. Ashikari-Hada, S.; Habuchi, H.; Kariya, Y.; Itoh, N.; Reddi, A.H.; Kimata, K. Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library. J. Biol. Chem., 2004, 279, 12346-12354.
50. Ostrovsky, O.; Berman, B.; Gallagher, J.; Mulloy, B.; Fernig, D.G.; Delehedde, M.; Ron, D. Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes. J. Biol. Chem., 2002, 277, 2444-2453.
51. Kovensky, J.; Duchaussoy; P.; Bono, F.; Salmivirta, M.; Sizun, P.; Herbert, J.-M.; Petitou, M.; Sinaÿ, P. A synthetic heparan sulfate pentasaccharide, exclusively containing L-iduronic acid, displays higher affinity for FGF-2 than its D-glucuronic acid containing isomers. Bioorg. Med. Chem., 1999, 7, 1567-1580.
52. Angulo, J.; Ojeda, R.; de Paz, J.L.; Lucas, R.; Nieto, P.M.; Lozano, R.M.; Redondo-Horcajo, M.; Gimenez-Gallego, G.; Martin-Lomas, M. The activation of fibroblast growth factors (FGFs) by glycosaminoglycans: influence of the sulfation pattern on the biological activity of FGF-1. ChemBioChem, 2004, 5, 55-61.
53. Petitou, M.; van Boeckel, C.A.A. A Synthetic Antithrombin III Binding Pentasaccharide Is Now a Drug! What Comes Next? Angew. Chem. Int. Ed. Engl., 2004, 43, 3118-3133.
54. (a) Das, S.K.; Mallet, J.-M.; Esnault, J.; Driguez, P.-A.; Duchaussoy; P.; Sizun, P.; Hérault, J.-P.; Herbert, J.-M.; Petitou, M.; Sinaÿ, P. Synthesis of conformationally locked carbohydrates: A skew-boat conformation of l-iduronic acid governs the antithrombotic activity of heparin. Angew. Chem. Int. Ed. Engl., 2001, 40, 1670-1673.
55. (b) Kovensky, J.; Mallet, J.-M.; Esnault, J.; Driguez, P.-A.; Sizun, P.; Hérault, J.-P.; Herbert, J.-M.; Petitou, M.; Sinaÿ, P. Further evidence for the critical role of a skew-boat conformation of L-iduronic acid in the activation of antithrombin. Eur. J. Org. Chem., 2002, 3595-3603.
56. Liu, L.; Bytheway, I.; Karoli, T.; Fairweather, J.K.; Cochran, S.; Li,C.; Ferro,V. Design, synthesis, FGF-1 binding, and molecular modeling studies of conformationally flexible heparin mimetic disaccharides. Bioorg. Med. Chem. Lett., 2008, 18, 344-349.
57. Mikami, T.; Sugahara, K. The biological importance of specific sulfation of chondroitin sulfate/dermatan sulfate in their functional expression. Trends Glycosci. Glycotechnol., 2006, 18, 165-183.
58. Zajonc, D. M.; Maricic, I.; Wu, D.; Halder, R.; Roy, K.; Wong, C.-H.; Kumar, V.; Wilson, I. A. Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity. J. Exp. Med., 2005, 202, 1517-1526.
59. (a) Yoshikawa, M.; Murakami, T.; Shimada, H.; Matsuda, H.; Yamahara, J.; Tanabe, G.; Muraoka, O. Salacinol, potent antidiabetic principle with unique thiosugar sulfonium sulfate structure from the Ayurvedic traditional medicine Salacia reticulata in Sri Lanka and India. Tetrahedron Lett., 1997, 38, 8367-8370.
60. (b) Yoshikawa, M.; Murakami, T.; Yashiro, K.; Matsuda, H. Kotalanol, a potent alpha-glucosidase inhibitor with thiosugar sulfonium sulfate structure, from antidiabetic ayurvedic medicine Salacia reticulata. Chem. Pharm. Bull. (Tokyo), 1998, 46, 1339-1340.
61. Rossi, E.J.; Sim, L.; Kuntz, D.A.; Hahn, D.; Johnston, B.D.; Ghavami, A.; Szczepina, M.G.; Kumar, N.S.; Sterchi, E.E.; Nichols, B.L.; Pinto, B.M.; Rose, D.R. Inhibition of recombinant human maltase glucoamylase by salacinol and derivatives. FEBS J., 2006, 273, 2673-2683.
62. Kuntz, D.A.; Ghavami, A.; Johnston, B.D.; Pinto, B.M.; Rose, D.R. Crystallographic analysis of the interactions of Drosophila melanogaster Golgi α-mannosidase II with the naturally occurring glycomimetic salacinol and its analogues. Tetrahedron: Asymm., 2005, 16, 25-32.
63. (a) Sakuda, S.; Isogai, A.; Matsumoto, S.; Suzuki, A. Search for microbial insect growth regulators II. Allosamidin, a novel insect chitinase inhibitor. J. Antibiot., 1987, 40, 296-300.
64. (b) Londershausen, M.; Turberg, A.; Bieseler, B.; Lennertz, M.; Peter, M.G. Characterization and inhibitor studies of chitinases from a parasitic blowfly (Lucilia cuprina), a tick (Boophilus microplus), an intestinal nematode (Haemonchus con-tortus) and a bean (Phaseolus vulgaris). Pestic. Sci., 1996, 48, 305-314.
65. Bultel, L.; Saguez, J.; Giordanengo, P.; Kovensky, J. 2007. Composé du type disaccharide, composition contenant un tel composé et procédé de fabrication d'un tel composé phytosanitaire. French Patent No 07/08313.
66. Terwisscha van Scheltinga, A.C.; Armand, S.; Kalk, K.H.; Isogai, A.; Henrissat, B.; Dijkstra, B.W. Stereochemistry of chitin hydrolysis by a plant chitinase/lysozyme and x-ray structure of a complex with allosamidin evidence for substrate assisted catalysis. Biochemistry, 1995, 34, 15619-15623.